Novasep will develop an R&D-phase pilot facility for highly potent active ingredients (HPAIs) as part of a consortium funded by the French government to develop innovative cancer therapies.
Business Wire
Tuesday 17 March 2009
Novasep to build HPAI facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment